We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Sarepta Therapeutics has signed a global research and option agreement with Codiak BioSciences for the design and development of engineered exosome therapeutics to treat rare, neuromuscular diseases.